Esra Aşık

Prognostic impact of pathological complete response in hormone receptor–positive/HER2-negative breast cancer treated with neoadjuvant chemotherapy: a multicenter cohort study

Pathological complete response (pCR) is an established surrogate endpoint in aggressive breast cancer subtypes; however, its prognostic role in hormone receptor (HR)-positive/HER2-negative disease remains controversial. We aimed to evaluate clinicopathological predictors of pCR a...